Pictet Asset Management Holding Sa Protagonist Therapeutics, Inc Transaction History
Pictet Asset Management Holding Sa
- $88 Billion
- Q3 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 7,298 shares of PTGX stock, worth $327,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,298
Previous 5,848
24.79%
Holding current value
$327,169
Previous $202,000
61.88%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PTGX
# of Institutions
247Shares Held
56.4MCall Options Held
76.3KPut Options Held
114K-
Farallon Capital Management LLC San Francisco, CA5.86MShares$263 Million1.32% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$258 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$243 Million3.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$189 Million0.0% of portfolio
-
State Street Corp Boston, MA3.18MShares$143 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.2B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...